Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Lang currently holds 223,776 shares of Myovant Sciences Ltd. (MYOV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Lang has been a net seller of MYOV stock. They have purchased $0 and sold $4.0M worth of shares.
Matthew Lang's most recent insider trade was on Apr 15, 2026, when they sold 223,776 shares at $0.00 per share.
Matthew Lang serves as Executive at Myovant Sciences Ltd. (MYOV). They have executed 43 insider transactions totaling $4.0M over their tenure at the company.
Matthew Lang holds the position of Executive at Myovant Sciences Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Matthew Lang has shown a selling trading pattern, with $0 in total purchases and $4.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Lang was on Mar 15, 2021, when they sold $752.1K worth of MYOV shares. This transaction involved 30,000 shares at $25.07 per share.
Matthew Lang currently owns 223,776 shares of Myovant Sciences Ltd. (MYOV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Lang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Lang has 43 Form 4 filings on record as an insider at Myovant Sciences Ltd..
Set alerts for Matthew Lang and 40,000+ other insiders.